Researchers employ microfluidic diffusional sizing characterize neutralizing antibody affinity to SARS-CoV-2

SARS-CoV-2 has rampantly spread around the globe and continues to cause unprecedented loss through ongoing waves of (re)infection. Increasing our understanding of the protection against infection with SARS-CoV-2 is critical to ending the pandemic.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup